Sequoia Financial Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587K Buy
1,108
+84
+8% +$38.8K ﹤0.01% 1250
2026
Q1
$492K Sell
1,024
-600
-37% -$307K ﹤0.01% 1286
2025
Q4
$912K Buy
1,624
+574
+55% +$326K 0.01% 932
2025
Q3
$540K Buy
1,050
+269
+34% +$117K ﹤0.01% 1098
2025
Q2
$245K Sell
781
-44
-5% -$13.2K ﹤0.01% 1374
2025
Q1
$251K Sell
825
-57
-6% -$19.2K ﹤0.01% 1149
2024
Q4
$293K Buy
882
+84
+11% +$28.5K ﹤0.01% 1027
2024
Q3
$266K Buy
798
+195
+32% +$74.1K ﹤0.01% 1028
2024
Q2
$248K Buy
603
+106
+21% +$42K ﹤0.01% 975
2024
Q1
$201K Sell
497
-1,467
-75% -$516K ﹤0.01% 1066
2023
Q4
$602K Buy
+1,964
New +$530K 0.01% 682

Other funds holding MEDP

Sequoia Financial Advisors's MEDP Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Medpace (MEDP) stake by 8.2% in Q2 2026, buying an estimated $38.8K and bringing the position to 1,108 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

Sequoia Financial Advisors first reported a position in MEDP in Q4 2023 and has held it in 11 quarters since. The position peaked at $912K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Sequoia Financial Advisors held 1,108 shares of Medpace worth $587K as of Q2 2026.
  • Sequoia Financial Advisors bought 84 Medpace shares in Q2 2026, an estimated $38.8K.
  • Medpace made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1250 holding.
  • Sequoia Financial Advisors first reported a position in Medpace in Q4 2023 and has held it in 11 quarters since.
  • Sequoia Financial Advisors's Medpace position peaked at $912K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.